Serum C-reactive Protein Level and Distribution in Chronic Obstructive Pulmonary Disease Versus Healthy Controls: a Case–Control Study from Iran

[1]  Ioanna Kougioumtzi,et al.  Airway inflammation in chronic obstructive pulmonary disease. , 2014, Journal of thoracic disease.

[2]  Yonggang Zhang,et al.  C-Reactive Protein Levels Predict Bacterial Exacerbation in Patients With Chronic Obstructive Pulmonary Disease , 2013, The American journal of the medical sciences.

[3]  Y. Zhang,et al.  Association between C-reactive Protein Concentration and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis , 2012, The Journal of international medical research.

[4]  M. Rahimi-Rad,et al.  High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease. , 2012, Pneumologia.

[5]  C. Pedone,et al.  C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD). , 2011, Archives of gerontology and geriatrics.

[6]  J. Soriano,et al.  Systemic inflammation in chronic obstructive pulmonary disease: a population-based study , 2010, Respiratory research.

[7]  J. Wedzicha,et al.  The potential value of biomarkers in diagnosis and staging of COPD and exacerbations. , 2010, Seminars in respiratory and critical care medicine.

[8]  A. Wouters,et al.  [COPD: from obstructive lung disease to chronic systemic inflammatory syndrome?]. , 2009, Pneumologie.

[9]  A. Buist,et al.  Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. , 2009, Respiratory medicine.

[10]  K. Piehl-Aulin,et al.  Increased Serum Inflammatory Markers in the Absence of Clinical and Skeletal Muscle Inflammation in Patients with Chronic Obstructive Pulmonary Disease , 2009, Respiration.

[11]  F. Karadağ,et al.  Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease , 2009, Scandinavian journal of clinical and laboratory investigation.

[12]  M. Wolzt,et al.  Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. , 2008, Clinical science.

[13]  I. Adcock,et al.  Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction , 2008, European Respiratory Journal.

[14]  B. Celli,et al.  C-reactive protein levels and survival in patients with moderate to very severe COPD. , 2008, Chest.

[15]  M. Gokirmak,et al.  C-Reactive Protein Levels in Patients with Chronic Obstructive Pulmonary Disease: Role of Infection , 2008, Medical Principles and Practice.

[16]  F. Karadağ,et al.  The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. , 2008, European journal of internal medicine.

[17]  K. Rabe,et al.  Complex chronic comorbidities of COPD , 2008, European Respiratory Journal.

[18]  S. Lewis,et al.  ESR or CRP? A comparison of their clinical utility , 2007, Hematology.

[19]  B. Heidari,et al.  The value of changes in CRP and ESR for predicting treatment response in rheumatoid arthritis , 2007 .

[20]  S. Bojesen,et al.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[21]  John R Hurst,et al.  Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[22]  N. Anthonisen,et al.  C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease , 2006, Thorax.

[23]  R. Stockley,et al.  Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity – a common inflammatory phenotype? , 2006, Respiratory research.

[24]  T. Forst,et al.  High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. , 2006, Diabetes technology & therapeutics.

[25]  D. Sin,et al.  Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[26]  A Senthilselvan,et al.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.

[27]  L. Koenderman,et al.  Systemic inflammation in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[28]  D. Sin,et al.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. , 2003, Circulation.

[29]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.

[30]  S. Bedell,et al.  Erythrocyte sedimentation rate. From folklore to facts. , 1985, The American journal of medicine.

[31]  I. Kushner.  THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.

[32]  M. Feldman,et al.  C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. , 2013, Translational research : the journal of laboratory and clinical medicine.

[33]  B. Heidari.  The importance of C-reactive protein and other inflammatory markers in patients with chronic obstructive pulmonary disease. , 2012, Caspian journal of internal medicine.

[34]  B. Lazovic.  Correlation of CRP and serum level of fibrinogen with severity of disease in chronic obstructive pulmonary disease patients. , 2012, Medical archives.

[35]  Li-juan Guo,et al.  [Association between the erythrocyte sedimentation rate, serum C-reactive protein and risk of lung cancer]. , 2010, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[36]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.